S1P receptor agonist 2 (compound 1) is an agonist of the S1P5 receptor with selectivity over S1P1 and/or S1P3 receptors; it can be used for studying the endogenous S1P signaling system and for research into alleviating or preventing central nervous system (CNS) disorders, such as neurodegenerative diseases.